AR055597A1 - Uso de sales de tiotripio en el tratamiento del asma persistente severa - Google Patents
Uso de sales de tiotripio en el tratamiento del asma persistente severaInfo
- Publication number
- AR055597A1 AR055597A1 ARP060103410A ARP060103410A AR055597A1 AR 055597 A1 AR055597 A1 AR 055597A1 AR P060103410 A ARP060103410 A AR P060103410A AR P060103410 A ARP060103410 A AR P060103410A AR 055597 A1 AR055597 A1 AR 055597A1
- Authority
- AR
- Argentina
- Prior art keywords
- treatment
- persistent asthma
- severe persistent
- salts
- tiotripe
- Prior art date
Links
- 208000006673 asthma Diseases 0.000 title abstract 3
- 230000002085 persistent effect Effects 0.000 title abstract 3
- LERNTVKEWCAPOY-DZZGSBJMSA-N tiotropium Chemical class O([C@H]1C[C@@H]2[N+]([C@H](C1)[C@@H]1[C@H]2O1)(C)C)C(=O)C(O)(C=1SC=CC=1)C1=CC=CS1 LERNTVKEWCAPOY-DZZGSBJMSA-N 0.000 abstract 3
- 150000001450 anions Chemical class 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 abstract 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 abstract 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 abstract 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 abstract 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 abstract 1
- 229910002651 NO3 Inorganic materials 0.000 abstract 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 abstract 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 abstract 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 abstract 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 abstract 1
- 229940095064 tartrate Drugs 0.000 abstract 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5386—1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05107266 | 2005-08-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR055597A1 true AR055597A1 (es) | 2007-08-29 |
Family
ID=35432680
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP060103410A AR055597A1 (es) | 2005-08-06 | 2006-08-04 | Uso de sales de tiotripio en el tratamiento del asma persistente severa |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US20070032516A1 (enExample) |
| EP (1) | EP1915158A1 (enExample) |
| JP (1) | JP2009504604A (enExample) |
| KR (1) | KR20080039974A (enExample) |
| CN (1) | CN101237872A (enExample) |
| AR (1) | AR055597A1 (enExample) |
| AU (1) | AU2006277968A1 (enExample) |
| BR (1) | BRPI0614394A2 (enExample) |
| CA (1) | CA2617717C (enExample) |
| IL (1) | IL189248A0 (enExample) |
| MX (1) | MX2008001506A (enExample) |
| NZ (1) | NZ566399A (enExample) |
| RU (1) | RU2422144C2 (enExample) |
| TW (1) | TWI409072B (enExample) |
| WO (1) | WO2007017438A1 (enExample) |
| ZA (1) | ZA200800186B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7250426B2 (en) | 2002-11-29 | 2007-07-31 | Boehringer Ingelheim Pharma Gmbh & Co Kg | Tiotropium-containing pharmaceutical combination for inhalation |
| WO2007077162A1 (en) * | 2006-01-04 | 2007-07-12 | Boehringer Ingelheim International Gmbh | Use of tiotropium salts in the treatment of moderate persistent asthma |
| MX2012005711A (es) * | 2009-11-17 | 2012-10-05 | Cipla Ltd | Soluciones de inhalacion. |
| GB201200525D0 (en) | 2011-12-19 | 2012-02-29 | Teva Branded Pharmaceutical Prod R & D Inc | An inhalable medicament |
| US10034866B2 (en) | 2014-06-19 | 2018-07-31 | Teva Branded Pharmaceutical Products R&D, Inc. | Inhalable medicament comprising tiotropium |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3931041C2 (de) * | 1989-09-16 | 2000-04-06 | Boehringer Ingelheim Kg | Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
| US5610163A (en) * | 1989-09-16 | 1997-03-11 | Boehringer Ingelheim Gmbh | Esters of thienyl carboxylic acids and amino alcohols and their quaternization products |
| US5888396A (en) * | 1996-12-17 | 1999-03-30 | Perriello; Felix Anthony | Bioremediation of pollutants with butane-utilizing bacteria |
| US6156503A (en) * | 1997-03-03 | 2000-12-05 | The Regents Of The University Of California | Diagnosing asthma patients predisposed to adverse β-agonist reactions |
| GB9902689D0 (en) * | 1999-02-08 | 1999-03-31 | Novartis Ag | Organic compounds |
| GB0009583D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Respiratory formulations |
| CA2425539C (en) * | 2000-10-12 | 2007-04-03 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Crystalline monohydrate, processes for the preparation thereof and the use thereof for preparing a pharmaceutical composition |
| US6908928B2 (en) * | 2000-10-12 | 2005-06-21 | Bi Pharma Kg. | Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions |
| US6919325B2 (en) * | 2001-09-14 | 2005-07-19 | Boehringer Ingelheim Pharma Kg | Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts |
| DE10216036A1 (de) * | 2002-04-11 | 2003-10-23 | Boehringer Ingelheim Pharma | Aerosolformulierung für die Inhalation enthaltend ein Tiotropiumsalz |
| WO2004014293A2 (en) * | 2002-06-12 | 2004-02-19 | Epigenesis Pharmaceuticals, Inc. | Combination of anti-muscarinic agents and non-glucocorticoid steroids |
| EP1531866A1 (en) * | 2002-08-29 | 2005-05-25 | Cipla Ltd. | Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids |
| US7968717B2 (en) * | 2003-11-03 | 2011-06-28 | Boehringer Ingelhein International Gmbh | Crystalline anhydrate with anticholinergic efficacy |
| SE0303571D0 (sv) * | 2003-12-03 | 2003-12-22 | Microdrug Ag | Medical product for moisture-sensitive medicaments |
| SE0303570L (sv) * | 2003-12-03 | 2005-06-04 | Microdrug Ag | Fukt-känslig medicinsk produkt |
| AU2006244683A1 (en) * | 2005-05-10 | 2006-11-16 | Synergenz Bioscience Limited | Methods and compositions for assessment of pulmonary function and disorders |
| AU2006248189A1 (en) * | 2005-05-20 | 2006-11-23 | Synergenz Bioscience Limited | Methods of analysis of polymorphisms and uses thereof |
| US20070167480A1 (en) * | 2005-12-19 | 2007-07-19 | Sicor Inc. | Pure and stable tiotropium bromide |
| WO2007077162A1 (en) | 2006-01-04 | 2007-07-12 | Boehringer Ingelheim International Gmbh | Use of tiotropium salts in the treatment of moderate persistent asthma |
-
2006
- 2006-08-02 CA CA2617717A patent/CA2617717C/en not_active Expired - Fee Related
- 2006-08-02 NZ NZ566399A patent/NZ566399A/en unknown
- 2006-08-02 JP JP2008525548A patent/JP2009504604A/ja active Pending
- 2006-08-02 MX MX2008001506A patent/MX2008001506A/es active IP Right Grant
- 2006-08-02 CN CNA2006800288506A patent/CN101237872A/zh active Pending
- 2006-08-02 RU RU2008108302/15A patent/RU2422144C2/ru active
- 2006-08-02 EP EP20060792647 patent/EP1915158A1/en not_active Ceased
- 2006-08-02 BR BRPI0614394-6A patent/BRPI0614394A2/pt not_active Application Discontinuation
- 2006-08-02 WO PCT/EP2006/064958 patent/WO2007017438A1/en not_active Ceased
- 2006-08-02 AU AU2006277968A patent/AU2006277968A1/en not_active Abandoned
- 2006-08-02 KR KR1020087005564A patent/KR20080039974A/ko not_active Ceased
- 2006-08-03 US US11/462,139 patent/US20070032516A1/en not_active Abandoned
- 2006-08-04 TW TW095128580A patent/TWI409072B/zh active
- 2006-08-04 AR ARP060103410A patent/AR055597A1/es unknown
-
2008
- 2008-01-08 ZA ZA200800186A patent/ZA200800186B/xx unknown
- 2008-02-04 IL IL189248A patent/IL189248A0/en unknown
-
2009
- 2009-02-19 US US12/388,879 patent/US20090163531A1/en not_active Abandoned
-
2012
- 2012-09-24 US US13/625,589 patent/US20130245059A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NZ566399A (en) | 2011-07-29 |
| CA2617717C (en) | 2014-02-11 |
| RU2422144C2 (ru) | 2011-06-27 |
| TW200744606A (en) | 2007-12-16 |
| US20130245059A1 (en) | 2013-09-19 |
| WO2007017438A1 (en) | 2007-02-15 |
| CA2617717A1 (en) | 2007-02-15 |
| RU2008108302A (ru) | 2009-09-20 |
| EP1915158A1 (en) | 2008-04-30 |
| ZA200800186B (en) | 2009-04-29 |
| IL189248A0 (en) | 2008-08-07 |
| KR20080039974A (ko) | 2008-05-07 |
| US20070032516A1 (en) | 2007-02-08 |
| AU2006277968A1 (en) | 2007-02-15 |
| MX2008001506A (es) | 2008-04-07 |
| BRPI0614394A2 (pt) | 2011-03-29 |
| TWI409072B (zh) | 2013-09-21 |
| JP2009504604A (ja) | 2009-02-05 |
| US20090163531A1 (en) | 2009-06-25 |
| CN101237872A (zh) | 2008-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY28527A1 (es) | Formularios de aerosol destinadaa la inhalación, que contiene un agente anticolinergico | |
| ES2552237T3 (es) | Composición para inhalación que contiene aclidinio para el tratamiento del asma | |
| AR072442A1 (es) | Metodo para la terapia del cancer, uso, kit | |
| RU2011139107A (ru) | Специфические соединения диарилгидантоина и диарилтиогидантоина | |
| DE50307659D1 (de) | Inhalative arzneimittel enthaltend ein neues anticholinergikum in kombination mit corticosteroiden und betamimetika | |
| WO2009156735A3 (en) | New therapeutic agents | |
| CO6170341A2 (es) | Formulacion de aerosol que contiene derivados de benzoxazin-3onas | |
| JP2015512943A5 (enExample) | ||
| MX2009010165A (es) | Nuevas imidazo[4,5-b]piridina-7-carboxamidas 704. | |
| AR057099A1 (es) | Una forma cristalina, un proceso de preparacion y composicion farmaceutica | |
| AR039275A1 (es) | Medicamento que contiene esteroides y un nuevo anticolinergico | |
| JP2015527374A5 (enExample) | ||
| SA519401614B1 (ar) | مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب | |
| AR102640A1 (es) | Composición para cuidado bucal que contiene sales de zinc y carbonato de calcio | |
| UA96304C2 (en) | 2-METHYLMORPHOLINE PYRIDO-, PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS | |
| AR058082A1 (es) | Formulacion en aerosol para la inhalacion de beta- agonistas | |
| AR055597A1 (es) | Uso de sales de tiotripio en el tratamiento del asma persistente severa | |
| TW200639156A (en) | New compounds | |
| AR059126A1 (es) | Uso de sales de tiotropio en el tratamiento del asma persistente moderada | |
| TW200531688A (en) | Novel pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents | |
| AR062476A1 (es) | Beta - agonistas enentiomericamente puros, procedimientos para su preparacion y su uso como medicamentos | |
| UY28979A1 (es) | Derivados de hidrocloruros de 3-carboxamida, composiciones farmacéuticas que los contienen, procedimiento de preparación y su uso, útiles como inhibidores selectivos de gsk3 | |
| PH12013501844A1 (en) | Formulation comprising phenylaminopyrimidine derivatives as active agent | |
| AR059225A1 (es) | Sal de citrato, proceso de preparacion y su actividad en terapia | |
| AR049096A1 (es) | Formulacion en aerosol sin gas propelente para la inhalacion de beta-agonistas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |